80 results
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
Papillomavirus Infections ... infection ... 3 years • Co-testing ... Treatment #management #opportunistic ... #infections #HIVAIDS
CNS Infection in HIV / AIDS - Differential Diagnosis Framework

Principles of HIV-Associated CNS Opportunistic Infections:
 •
should be based on clinical ... status, and focal neurologic ... of serum CrAg testing ... comparable to CSF testing ... InfectiousDiseases #Neurology
Interpretation of Hepatitis B Serologies 
HBsAg - HBcAb (total) - HBcAb (IgM) - HBsAb
Susceptible to HBV
Immune
infection Immune ... HBV Resolved infection ... level" chronic infection ... HepBVirus #Serologies #serology ... interpreation #testing
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Bacterial Enteric Infections ... in HIV-AIDS Preventing ... Clostridium difficile Infection ... Treatment #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Preventing and Treating ... in HIV-AIDS Preventing ... Treating Acute Infection ... to 5 mg/kg/day IV ... Treatment #management #opportunistic
Demyelinating Diseases - Differential Diagnosis
 • Inflammatory: MS, ADEM, NMO, Paraneoplastic, Sjogren's, Polyarteritis nodosa, SLE
 •
Inflammatory: MS ... nodosa, SLE • Infectious ... : HIV, Lyme, Neurosyphilis ... Diagnosis #causes #neurology
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
Coccidiodomycosis in HIV-AIDS ... Infections (Such ... with positive serology ... • Use until clinical ... Treatment #management #opportunistic
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
Recommendations for Treating ... in HIV-AIDS Treating ... 800 mg) PO (or IV ... 800 mg) PO (or IV ... Treatment #management #opportunistic
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
Recommendations for Treating ... Leishmaniasis in HIV-AIDS ... Treating Visceral ... Treatment #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
) Infections in ... HIV-AIDS Treating ... Infections: • ... Treatment #management #opportunistic ... #infections #HIVAIDS